A Randomized Trial Comparing Bangerter Filters and Patching for the Treatment of Moderate Amblyopia in Children

To determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with moderate amblyopia. Randomized, clinical trial. We enrolled 186 children, 3 to <10 years old, with moderate amblyopia (20/40–20/80). Children were ran...

Full description

Saved in:
Bibliographic Details
Published inOphthalmology (Rochester, Minn.) Vol. 117; no. 5; pp. 998 - 1004.e6
Main Authors Rutstein, Robert P, Quinn, Graham E, Lazar, Elizabeth L, Beck, Roy W, Bonsall, Dean J, Cotter, Susan A, Crouch, Eric R, Holmes, Jonathan M, Hoover, Darren L, Leske, David A, Lorenzana, Ingryd J, Repka, Michael X, Suh, Donny W
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.05.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with moderate amblyopia. Randomized, clinical trial. We enrolled 186 children, 3 to <10 years old, with moderate amblyopia (20/40–20/80). Children were randomly assigned to receive either daily patching or to use a Bangerter filter on the spectacle lens in front of the fellow eye. Study visits were scheduled at 6, 12, 18, and 24 weeks. Visual acuity in amblyopic eyes at 24 weeks. At 24 weeks, amblyopic eye improvement averaged 1.9 lines in the Bangerter group and 2.3 lines in the patching group (difference in mean visual acuities between groups adjusted for baseline acuity = 0.38 line). The upper limit of a 1-sided 95% confidence interval was 0.76 line, which slightly exceeded a prespecified noninferiority limit of <0.75 line. Similar percentages of subjects in each group improved ≥3 lines (Bangerter group 38% vs patching group 35%; P = 0.61) or had ≥20/25 amblyopic eye acuity (36% vs 31%, respectively; P = 0.86). There was a lower treatment burden in the Bangerter group as measured with the Amblyopia Treatment Index. With Bangerter filters, neither a fixation switch to the amblyopic eye nor induced blurring in the fellow eye to worse than that of the amblyopic eye was required for visual acuity improvement. Because the average difference in visual acuity improvement between Bangerter filters and patching was less than half a line, and there was lower burden of treatment on the child and family, Bangerter filter treatment is a reasonable option to consider for initial treatment of moderate amblyopia. The authors have no proprietary or commercial interest in any of the materials discussed in this article.
AbstractList To determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with moderate amblyopia. Randomized, clinical trial. We enrolled 186 children, 3 to <10 years old, with moderate amblyopia (20/40-20/80). Children were randomly assigned to receive either daily patching or to use a Bangerter filter on the spectacle lens in front of the fellow eye. Study visits were scheduled at 6, 12, 18, and 24 weeks. Visual acuity in amblyopic eyes at 24 weeks. At 24 weeks, amblyopic eye improvement averaged 1.9 lines in the Bangerter group and 2.3 lines in the patching group (difference in mean visual acuities between groups adjusted for baseline acuity = 0.38 line). The upper limit of a 1-sided 95% confidence interval was 0.76 line, which slightly exceeded a prespecified noninferiority limit of <0.75 line. Similar percentages of subjects in each group improved > or =3 lines (Bangerter group 38% vs patching group 35%; P = 0.61) or had > or =20/25 amblyopic eye acuity (36% vs 31%, respectively; P = 0.86). There was a lower treatment burden in the Bangerter group as measured with the Amblyopia Treatment Index. With Bangerter filters, neither a fixation switch to the amblyopic eye nor induced blurring in the fellow eye to worse than that of the amblyopic eye was required for visual acuity improvement. Because the average difference in visual acuity improvement between Bangerter filters and patching was less than half a line, and there was lower burden of treatment on the child and family, Bangerter filter treatment is a reasonable option to consider for initial treatment of moderate amblyopia.
To determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with moderate amblyopia.OBJECTIVETo determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with moderate amblyopia.Randomized, clinical trial.DESIGNRandomized, clinical trial.We enrolled 186 children, 3 to <10 years old, with moderate amblyopia (20/40-20/80).PARTICIPANTSWe enrolled 186 children, 3 to <10 years old, with moderate amblyopia (20/40-20/80).Children were randomly assigned to receive either daily patching or to use a Bangerter filter on the spectacle lens in front of the fellow eye. Study visits were scheduled at 6, 12, 18, and 24 weeks.METHODSChildren were randomly assigned to receive either daily patching or to use a Bangerter filter on the spectacle lens in front of the fellow eye. Study visits were scheduled at 6, 12, 18, and 24 weeks.Visual acuity in amblyopic eyes at 24 weeks.MAIN OUTCOME MEASURESVisual acuity in amblyopic eyes at 24 weeks.At 24 weeks, amblyopic eye improvement averaged 1.9 lines in the Bangerter group and 2.3 lines in the patching group (difference in mean visual acuities between groups adjusted for baseline acuity = 0.38 line). The upper limit of a 1-sided 95% confidence interval was 0.76 line, which slightly exceeded a prespecified noninferiority limit of <0.75 line. Similar percentages of subjects in each group improved > or =3 lines (Bangerter group 38% vs patching group 35%; P = 0.61) or had > or =20/25 amblyopic eye acuity (36% vs 31%, respectively; P = 0.86). There was a lower treatment burden in the Bangerter group as measured with the Amblyopia Treatment Index. With Bangerter filters, neither a fixation switch to the amblyopic eye nor induced blurring in the fellow eye to worse than that of the amblyopic eye was required for visual acuity improvement.RESULTSAt 24 weeks, amblyopic eye improvement averaged 1.9 lines in the Bangerter group and 2.3 lines in the patching group (difference in mean visual acuities between groups adjusted for baseline acuity = 0.38 line). The upper limit of a 1-sided 95% confidence interval was 0.76 line, which slightly exceeded a prespecified noninferiority limit of <0.75 line. Similar percentages of subjects in each group improved > or =3 lines (Bangerter group 38% vs patching group 35%; P = 0.61) or had > or =20/25 amblyopic eye acuity (36% vs 31%, respectively; P = 0.86). There was a lower treatment burden in the Bangerter group as measured with the Amblyopia Treatment Index. With Bangerter filters, neither a fixation switch to the amblyopic eye nor induced blurring in the fellow eye to worse than that of the amblyopic eye was required for visual acuity improvement.Because the average difference in visual acuity improvement between Bangerter filters and patching was less than half a line, and there was lower burden of treatment on the child and family, Bangerter filter treatment is a reasonable option to consider for initial treatment of moderate amblyopia.CONCLUSIONSBecause the average difference in visual acuity improvement between Bangerter filters and patching was less than half a line, and there was lower burden of treatment on the child and family, Bangerter filter treatment is a reasonable option to consider for initial treatment of moderate amblyopia.
Objective To determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with moderate amblyopia. Design Randomized, clinical trial. Participants We enrolled 186 children, 3 to <10 years old, with moderate amblyopia (20/40–20/80). Methods Children were randomly assigned to receive either daily patching or to use a Bangerter filter on the spectacle lens in front of the fellow eye. Study visits were scheduled at 6, 12, 18, and 24 weeks. Main Outcome Measures Visual acuity in amblyopic eyes at 24 weeks. Results At 24 weeks, amblyopic eye improvement averaged 1.9 lines in the Bangerter group and 2.3 lines in the patching group (difference in mean visual acuities between groups adjusted for baseline acuity = 0.38 line). The upper limit of a 1-sided 95% confidence interval was 0.76 line, which slightly exceeded a prespecified noninferiority limit of <0.75 line. Similar percentages of subjects in each group improved ≥3 lines (Bangerter group 38% vs patching group 35%; P = 0.61) or had ≥20/25 amblyopic eye acuity (36% vs 31%, respectively; P = 0.86). There was a lower treatment burden in the Bangerter group as measured with the Amblyopia Treatment Index. With Bangerter filters, neither a fixation switch to the amblyopic eye nor induced blurring in the fellow eye to worse than that of the amblyopic eye was required for visual acuity improvement. Conclusions Because the average difference in visual acuity improvement between Bangerter filters and patching was less than half a line, and there was lower burden of treatment on the child and family, Bangerter filter treatment is a reasonable option to consider for initial treatment of moderate amblyopia. Financial Disclosure(s) The authors have no proprietary or commercial interest in any of the materials discussed in this article.
To determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with moderate amblyopia. Randomized, clinical trial. We enrolled 186 children, 3 to <10 years old, with moderate amblyopia (20/40–20/80). Children were randomly assigned to receive either daily patching or to use a Bangerter filter on the spectacle lens in front of the fellow eye. Study visits were scheduled at 6, 12, 18, and 24 weeks. Visual acuity in amblyopic eyes at 24 weeks. At 24 weeks, amblyopic eye improvement averaged 1.9 lines in the Bangerter group and 2.3 lines in the patching group (difference in mean visual acuities between groups adjusted for baseline acuity = 0.38 line). The upper limit of a 1-sided 95% confidence interval was 0.76 line, which slightly exceeded a prespecified noninferiority limit of <0.75 line. Similar percentages of subjects in each group improved ≥3 lines (Bangerter group 38% vs patching group 35%; P = 0.61) or had ≥20/25 amblyopic eye acuity (36% vs 31%, respectively; P = 0.86). There was a lower treatment burden in the Bangerter group as measured with the Amblyopia Treatment Index. With Bangerter filters, neither a fixation switch to the amblyopic eye nor induced blurring in the fellow eye to worse than that of the amblyopic eye was required for visual acuity improvement. Because the average difference in visual acuity improvement between Bangerter filters and patching was less than half a line, and there was lower burden of treatment on the child and family, Bangerter filter treatment is a reasonable option to consider for initial treatment of moderate amblyopia. The authors have no proprietary or commercial interest in any of the materials discussed in this article.
Author Leske, David A
Bonsall, Dean J
Repka, Michael X
Rutstein, Robert P
Quinn, Graham E
Cotter, Susan A
Lazar, Elizabeth L
Holmes, Jonathan M
Crouch, Eric R
Suh, Donny W
Beck, Roy W
Lorenzana, Ingryd J
Hoover, Darren L
AuthorAffiliation Jaeb Center for Health Research, Tampa, FL 33647, USA
AuthorAffiliation_xml – name: Jaeb Center for Health Research, Tampa, FL 33647, USA
Author_xml – sequence: 1
  givenname: Robert P
  surname: Rutstein
  fullname: Rutstein, Robert P
– sequence: 2
  givenname: Graham E
  surname: Quinn
  fullname: Quinn, Graham E
– sequence: 3
  givenname: Elizabeth L
  surname: Lazar
  fullname: Lazar, Elizabeth L
– sequence: 4
  givenname: Roy W
  surname: Beck
  fullname: Beck, Roy W
– sequence: 5
  givenname: Dean J
  surname: Bonsall
  fullname: Bonsall, Dean J
– sequence: 6
  givenname: Susan A
  surname: Cotter
  fullname: Cotter, Susan A
– sequence: 7
  givenname: Eric R
  surname: Crouch
  fullname: Crouch, Eric R
– sequence: 8
  givenname: Jonathan M
  surname: Holmes
  fullname: Holmes, Jonathan M
– sequence: 9
  givenname: Darren L
  surname: Hoover
  fullname: Hoover, Darren L
– sequence: 10
  givenname: David A
  surname: Leske
  fullname: Leske, David A
– sequence: 11
  givenname: Ingryd J
  surname: Lorenzana
  fullname: Lorenzana, Ingryd J
– sequence: 12
  givenname: Michael X
  surname: Repka
  fullname: Repka, Michael X
– sequence: 13
  givenname: Donny W
  surname: Suh
  fullname: Suh, Donny W
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22773755$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20163869$$D View this record in MEDLINE/PubMed
BookMark eNqVkl2PEyEUholZ43ZX_4Ex3BivpsLAzDDGbFIbV03WaHS9JhTOdKgzUIFuUn-9TFrXj8RsvAFyznPew-HlDJ047wChx5TMKaH1883cb_vUq3lJSJtDc0L5PTSjFW8L3lB2gmYZo0XNS3KKzmLcEELqmvEH6LTMGSbqdob8An9SzvjRfgeDr4NVA176cauCdWv8Srk1hAQBX9ohbxFnFn9USfdTuvMBpx5yGag0gkvYd_i9NxBUArwYV8Peb63C1uFlbwcTwD1E9zs1RHh03M_Rl8vX18u3xdWHN--Wi6tC14SkQjWsXHUmr01jhK5aEGAElFCBqGvBCYAQatXxTgMrSUM4U6tG85ZCPlSGnaOLg-52txrB6Hy5oAa5DXZUYS-9svLPjLO9XPsbWYqaMyaywLOjQPDfdhCTHG3UMAzKgd9F2TBW0ZrQJpNPfm912-PnI2fg6RFQUauhC8ppG39xeUbWVFXm-IHTwccYoLtFKJGT53IjD57LyfMpmj3PZS_-KtM2qWT9NJgd7io-vhNkM24sBBm1BafB2AA6SePt_wrowTqb5_wKe4gbvwsuGy2pjKUk8vP0J6cvSVpCqahYFnj5b4G7-_8ADL70zA
CODEN OPHTDG
CitedBy_id crossref_primary_10_1016_j_jaapos_2010_04_004
crossref_primary_10_4103_sjopt_sjopt_212_23
crossref_primary_10_1155_2015_909848
crossref_primary_10_3368_aoj_66_1_87
crossref_primary_10_4103_ijo_IJO_852_22
crossref_primary_10_1016_S0140_6736_14_60522_5
crossref_primary_10_1016_j_ophtha_2017_10_008
crossref_primary_10_1364_BOE_424715
crossref_primary_10_3389_fnins_2021_622729
crossref_primary_10_1002_jmri_26708
crossref_primary_10_1007_s00417_010_1564_x
crossref_primary_10_1097_OPX_0b013e31826c5e06
crossref_primary_10_3390_children9020205
crossref_primary_10_1111_opo_12992
crossref_primary_10_1186_s12886_017_0624_y
crossref_primary_10_1016_j_jaapos_2024_103991
crossref_primary_10_1016_j_visres_2018_04_005
crossref_primary_10_1016_j_visres_2015_05_015
crossref_primary_10_4103_jcor_jcor_75_24
crossref_primary_10_1016_j_ophtha_2022_10_020
crossref_primary_10_1136_bjophthalmol_2013_303350
crossref_primary_10_3390_ijerph20031751
crossref_primary_10_1016_j_jaapos_2011_06_007
crossref_primary_10_1016_j_jaapos_2011_02_003
crossref_primary_10_1016_j_preteyeres_2023_101168
crossref_primary_10_1093_jpepsy_jst009
crossref_primary_10_1364_JOSAA_30_001441
crossref_primary_10_1364_BOE_489585
crossref_primary_10_3389_fnins_2019_01364
crossref_primary_10_1017_S0952523817000220
crossref_primary_10_1007_s00417_019_04254_w
crossref_primary_10_1016_j_ophtha_2013_04_008
crossref_primary_10_3368_aoj_63_1_14
crossref_primary_10_1111_cxo_12553
crossref_primary_10_1371_journal_pone_0237346
crossref_primary_10_1111_opo_13395
crossref_primary_10_1016_j_survophthal_2024_04_006
crossref_primary_10_1016_j_yaoo_2016_03_007
crossref_primary_10_1038_s41598_023_45057_8
crossref_primary_10_1080_09273972_2019_1618351
crossref_primary_10_1097_ICU_0000000000000409
crossref_primary_10_1155_2019_5157628
crossref_primary_10_1016_j_visres_2020_07_014
crossref_primary_10_1007_s00417_016_3334_x
crossref_primary_10_1002_14651858_CD006461_pub4
crossref_primary_10_1016_j_survophthal_2023_01_001
crossref_primary_10_1155_2019_5857243
crossref_primary_10_1038_eye_2011_4
crossref_primary_10_1186_s12886_022_02246_9
crossref_primary_10_1016_j_ajo_2020_07_053
crossref_primary_10_3760_cma_j_issn_0366_6999_20132998
crossref_primary_10_1007_s00417_021_05231_y
crossref_primary_10_1111_j_1755_3768_2011_02227_x
crossref_primary_10_1146_annurev_vision_100720_022550
crossref_primary_10_3389_fnins_2022_804576
crossref_primary_10_1080_09273972_2021_1914677
crossref_primary_10_1080_09273972_2022_2046114
crossref_primary_10_1016_j_preteyeres_2012_11_001
crossref_primary_10_1177_27536351241297249
crossref_primary_10_1007_s10792_023_02642_0
crossref_primary_10_1016_j_jaapos_2014_09_009
crossref_primary_10_1002_14651858_CD005136_pub3
crossref_primary_10_1016_j_ajo_2024_08_011
crossref_primary_10_3109_02713683_2015_1011280
crossref_primary_10_1002_14651858_CD005136_pub4
crossref_primary_10_1007_s40123_021_00394_7
crossref_primary_10_1016_j_visres_2015_02_012
crossref_primary_10_1016_j_ophtha_2011_06_043
crossref_primary_10_1016_j_ophtha_2011_06_041
crossref_primary_10_1080_02713683_2023_2275531
crossref_primary_10_1167_iovs_66_1_4
crossref_primary_10_1038_s41433_021_01669_w
crossref_primary_10_3368_aoj_62_1_1
crossref_primary_10_1016_j_survophthal_2022_08_003
crossref_primary_10_1167_iovs_65_3_33
crossref_primary_10_1186_s12886_018_0922_z
crossref_primary_10_1038_s41598_022_08010_9
crossref_primary_10_2147_OPTO_S454342
crossref_primary_10_1007_s10633_014_9462_x
crossref_primary_10_1016_j_ophtha_2022_06_016
crossref_primary_10_1016_j_jaapos_2010_11_015
crossref_primary_10_1097_OPX_0000000000001514
crossref_primary_10_1097_OPX_0000000000001431
crossref_primary_10_1007_s00417_017_3851_2
crossref_primary_10_1080_09273972_2019_1601743
crossref_primary_10_1016_j_ophtha_2011_12_003
crossref_primary_10_1016_j_visres_2015_01_029
Cites_doi 10.3368/aoj.51.1.84
10.1001/archopht.121.11.1625
10.1001/archopht.119.9.1345
10.1001/archopht.121.5.603
10.1001/archopht.123.4.437
10.1016/j.ophtha.2006.01.069
10.1001/archophthalmol.2008.520
10.1001/archopht.120.3.268
10.1016/S0002-9394(02)01825-1
10.1016/j.ophtha.2004.04.032
10.1016/j.jaapos.2008.04.017
10.1111/j.2517-6161.1972.tb00899.x
10.1016/j.jaapos.2008.04.012
10.1016/j.ophtha.2009.02.023
10.1001/archophthalmol.2008.107
10.1067/mpa.2001.117097
ContentType Journal Article
Copyright 2010 American Academy of Ophthalmology
American Academy of Ophthalmology
2015 INIST-CNRS
Copyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2010 American Academy of Ophthalmology
– notice: American Academy of Ophthalmology
– notice: 2015 INIST-CNRS
– notice: Copyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
CorporateAuthor Pediatric Eye Disease Investigator Group Writing Committee
CorporateAuthor_xml – name: Pediatric Eye Disease Investigator Group Writing Committee
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.ophtha.2009.10.014
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic



Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1549-4713
EndPage 1004.e6
ExternalDocumentID PMC2864338
20163869
22773755
10_1016_j_ophtha_2009_10_014
S0161642009011853
1_s2_0_S0161642009011853
Genre Multicenter Study
Comparative Study
Randomized Controlled Trial
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: National Eye Institute of National Institutes of Health, Department of Health and Human Services
  grantid: EY011751
– fundername: NEI NIH HHS
  grantid: UG1 EY011751
– fundername: NEI NIH HHS
  grantid: U10 EY011751
– fundername: NEI NIH HHS
  grantid: EY011751
GroupedDBID ---
--K
.1-
.55
.FO
.GJ
0R~
123
1B1
1CY
1P~
1~5
29N
4.4
457
4G.
53G
5RE
5VS
7-5
71M
AAEDT
AAEDW
AALRI
AAQFI
AAQQT
AAQXK
AAXUO
ABCQX
ABFRF
ABJNI
ABLJU
ABMAC
ABOCM
ABWVN
ACGFO
ACGFS
ACIUM
ACNCT
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
AEFWE
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AGCQF
AGQPQ
AIGII
AITUG
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BELOY
C5W
CS3
DU5
EBS
EFJIC
EFKBS
EJD
F5P
FDB
FEDTE
FGOYB
GBLVA
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
M27
M41
MO0
N4W
N9A
NQ-
O9-
OF-
OPF
OQ~
P2P
R2-
ROL
RPZ
SDG
SEL
SES
SSZ
UHS
UNMZH
UV1
WH7
X7M
XH2
XPP
Z5R
ZGI
ZXP
ADPAM
RIG
AAIAV
AGZHU
AHPSJ
ALXNB
ZA5
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c600t-a732bfd73277d8c59e8ed8e2e5e866840ee88abf4fce3207043ab7c491e3ab5d3
ISSN 0161-6420
1549-4713
IngestDate Thu Aug 21 14:01:24 EDT 2025
Fri Jul 11 04:33:47 EDT 2025
Mon Jul 21 05:54:50 EDT 2025
Mon Jul 21 09:14:18 EDT 2025
Sun Jul 06 05:03:22 EDT 2025
Thu Apr 24 23:06:15 EDT 2025
Fri Feb 23 02:14:51 EST 2024
Sun Feb 23 10:19:59 EST 2025
Tue Aug 26 19:03:10 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Human
Eye disease
Treatment
Filter
Vision disorder
Amblyopia
Ophthalmology
Child
Comparative study
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
Copyright 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c600t-a732bfd73277d8c59e8ed8e2e5e866840ee88abf4fce3207043ab7c491e3ab5d3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
OpenAccessLink http://www.aaojournal.org/article/S0161642009011853/pdf
PMID 20163869
PQID 733516017
PQPubID 23479
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2864338
proquest_miscellaneous_733516017
pubmed_primary_20163869
pascalfrancis_primary_22773755
crossref_primary_10_1016_j_ophtha_2009_10_014
crossref_citationtrail_10_1016_j_ophtha_2009_10_014
elsevier_sciencedirect_doi_10_1016_j_ophtha_2009_10_014
elsevier_clinicalkeyesjournals_1_s2_0_S0161642009011853
elsevier_clinicalkey_doi_10_1016_j_ophtha_2009_10_014
PublicationCentury 2000
PublicationDate 2010-05-01
PublicationDateYYYYMMDD 2010-05-01
PublicationDate_xml – month: 05
  year: 2010
  text: 2010-05-01
  day: 01
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
PublicationTitle Ophthalmology (Rochester, Minn.)
PublicationTitleAlternate Ophthalmology
PublicationYear 2010
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Lang (bib5) 1999; 14
(bib11) 2003; 121
(bib12) 2005; 123
(bib3) 2009; 127
(bib18) 2003; 121
Verbeke, Molenberghs (bib14) 2000
Odell, Leske, Hatt (bib17) 2008; 12
Cox (bib15) 1972; 34
(bib1) 2002; 120
Holmes, Beck, Repka (bib7) 2001; 119
Holmes, Strauber, Quinn (bib10) 2008; 12
Iacobucci, Archer, Furr (bib6) 2001; 51
(bib16) 2004; 111
Beck, Moke, Turpin (bib8) 2003; 135
Agervi, Kugelberg, Kugelberg (bib19) 2009; 116
(bib2) 2008; 126
(bib13) 2006; 113
Cole, Beck, Moke (bib9) 2001; 5
Bangerter (bib4) 1960; 136
Verbeke (10.1016/j.ophtha.2009.10.014_bib14) 2000
Odell (10.1016/j.ophtha.2009.10.014_bib17) 2008; 12
(10.1016/j.ophtha.2009.10.014_bib3) 2009; 127
(10.1016/j.ophtha.2009.10.014_bib12) 2005; 123
(10.1016/j.ophtha.2009.10.014_bib1) 2002; 120
(10.1016/j.ophtha.2009.10.014_bib16) 2004; 111
Holmes (10.1016/j.ophtha.2009.10.014_bib7) 2001; 119
Holmes (10.1016/j.ophtha.2009.10.014_bib10) 2008; 12
(10.1016/j.ophtha.2009.10.014_bib18) 2003; 121
Cole (10.1016/j.ophtha.2009.10.014_bib9) 2001; 5
Beck (10.1016/j.ophtha.2009.10.014_bib8) 2003; 135
(10.1016/j.ophtha.2009.10.014_bib2) 2008; 126
Agervi (10.1016/j.ophtha.2009.10.014_bib19) 2009; 116
Bangerter (10.1016/j.ophtha.2009.10.014_bib4) 1960; 136
Lang (10.1016/j.ophtha.2009.10.014_bib5) 1999; 14
Cox (10.1016/j.ophtha.2009.10.014_bib15) 1972; 34
Iacobucci (10.1016/j.ophtha.2009.10.014_bib6) 2001; 51
(10.1016/j.ophtha.2009.10.014_bib11) 2003; 121
(10.1016/j.ophtha.2009.10.014_bib13) 2006; 113
References_xml – volume: 127
  start-page: 22
  year: 2009
  end-page: 30
  ident: bib3
  article-title: Pharmacological plus optical penalization treatment for amblyopia: results of a randomized trial
  publication-title: Arch Ophthalmol
– volume: 12
  start-page: 581
  year: 2008
  end-page: 584
  ident: bib10
  article-title: Further validation of the Amblyopia Treatment Index parental questionnaire
  publication-title: J AAPOS
– volume: 135
  start-page: 194
  year: 2003
  end-page: 205
  ident: bib8
  article-title: A computerized method of visual acuity testing: adaptation of the Early Treatment of Diabetic Retinopathy Study testing protocol
  publication-title: Am J Ophthalmol
– volume: 34
  start-page: 187
  year: 1972
  end-page: 220
  ident: bib15
  article-title: Regression models and life-tables
  publication-title: J R Stat Soc Ser B
– volume: 12
  start-page: 555
  year: 2008
  end-page: 559
  ident: bib17
  article-title: The effect of Bangerter filters on optotype acuity, Vernier acuity, and contrast sensitivity
  publication-title: J AAPOS
– volume: 120
  start-page: 268
  year: 2002
  end-page: 278
  ident: bib1
  article-title: A randomized trial of atropine vs patching for treatment of moderate amblyopia in children
  publication-title: Arch Ophthalmol
– volume: 14
  start-page: 9
  year: 1999
  end-page: 10
  ident: bib5
  article-title: An efficient treatment and new criteria for cure of strabismic amblyopia: reading and Bangerter foils
  publication-title: Binocul Vis Strabismus Q
– volume: 123
  start-page: 437
  year: 2005
  end-page: 447
  ident: bib12
  article-title: Randomized trial of treatment of amblyopia in children aged 7 to 17 years
  publication-title: Arch Ophthalmol
– volume: 51
  start-page: 84
  year: 2001
  end-page: 91
  ident: bib6
  article-title: Bangerter foils in the treatment of moderate amblyopia
  publication-title: Am Orthopt J
– volume: 121
  start-page: 1625
  year: 2003
  end-page: 1632
  ident: bib18
  article-title: Impact of patching and atropine treatment on the child and family in the Amblyopia Treatment Study
  publication-title: Arch Ophthalmol
– volume: 126
  start-page: 1634
  year: 2008
  end-page: 1642
  ident: bib2
  article-title: Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial
  publication-title: Arch Ophthalmol
– volume: 116;
  start-page: 1475
  year: 2009
  end-page: 1480
  ident: bib19
  article-title: Treatment of anisometropic amblyopia with spectacles or in combination with translucent Bangerter filters
  publication-title: Ophthalmology
– volume: 111
  start-page: 2076
  year: 2004
  end-page: 2085
  ident: bib16
  article-title: A randomized trial of atropine regimens for treatment of moderate amblyopia in children
  publication-title: Ophthalmology
– volume: 119
  start-page: 1345
  year: 2001
  end-page: 1353
  ident: bib7
  article-title: The Amblyopia Treatment Study visual acuity testing protocol
  publication-title: Arch Ophthalmol
– volume: 121
  start-page: 603
  year: 2003
  end-page: 611
  ident: bib11
  article-title: A randomized trial of patching regimens for treatment of moderate amblyopia in children
  publication-title: Arch Ophthalmol
– volume: 113
  start-page: 904
  year: 2006
  end-page: 912
  ident: bib13
  article-title: A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children
  publication-title: Ophthalmology
– volume: 136
  start-page: 305
  year: 1960
  end-page: 331
  ident: bib4
  article-title: Occlusion in pleoptics and orthoptics
  publication-title: Klin Monatsblatter Augenheilkd Augenarztl Fortbild
– volume: 5
  start-page: 250
  year: 2001
  end-page: 254
  ident: bib9
  article-title: The Amblyopia Treatment Index
  publication-title: J AAPOS
– start-page: 41
  year: 2000
  end-page: 42
  ident: bib14
  article-title: Linear Mixed Models for Longitudinal Data
– volume: 51
  start-page: 84
  year: 2001
  ident: 10.1016/j.ophtha.2009.10.014_bib6
  article-title: Bangerter foils in the treatment of moderate amblyopia
  publication-title: Am Orthopt J
  doi: 10.3368/aoj.51.1.84
– volume: 121
  start-page: 1625
  year: 2003
  ident: 10.1016/j.ophtha.2009.10.014_bib18
  article-title: Impact of patching and atropine treatment on the child and family in the Amblyopia Treatment Study
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.121.11.1625
– volume: 14
  start-page: 9
  year: 1999
  ident: 10.1016/j.ophtha.2009.10.014_bib5
  article-title: An efficient treatment and new criteria for cure of strabismic amblyopia: reading and Bangerter foils
  publication-title: Binocul Vis Strabismus Q
– volume: 119
  start-page: 1345
  year: 2001
  ident: 10.1016/j.ophtha.2009.10.014_bib7
  article-title: The Amblyopia Treatment Study visual acuity testing protocol
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.119.9.1345
– volume: 121
  start-page: 603
  year: 2003
  ident: 10.1016/j.ophtha.2009.10.014_bib11
  article-title: A randomized trial of patching regimens for treatment of moderate amblyopia in children
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.121.5.603
– volume: 123
  start-page: 437
  year: 2005
  ident: 10.1016/j.ophtha.2009.10.014_bib12
  article-title: Randomized trial of treatment of amblyopia in children aged 7 to 17 years
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.123.4.437
– start-page: 41
  year: 2000
  ident: 10.1016/j.ophtha.2009.10.014_bib14
  article-title: Linear Mixed Models for Longitudinal Data
– volume: 113
  start-page: 904
  year: 2006
  ident: 10.1016/j.ophtha.2009.10.014_bib13
  article-title: A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2006.01.069
– volume: 127
  start-page: 22
  year: 2009
  ident: 10.1016/j.ophtha.2009.10.014_bib3
  article-title: Pharmacological plus optical penalization treatment for amblyopia: results of a randomized trial
  publication-title: Arch Ophthalmol
  doi: 10.1001/archophthalmol.2008.520
– volume: 136
  start-page: 305
  year: 1960
  ident: 10.1016/j.ophtha.2009.10.014_bib4
  article-title: Occlusion in pleoptics and orthoptics
  publication-title: Klin Monatsblatter Augenheilkd Augenarztl Fortbild
– volume: 120
  start-page: 268
  year: 2002
  ident: 10.1016/j.ophtha.2009.10.014_bib1
  article-title: A randomized trial of atropine vs patching for treatment of moderate amblyopia in children
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.120.3.268
– volume: 135
  start-page: 194
  year: 2003
  ident: 10.1016/j.ophtha.2009.10.014_bib8
  article-title: A computerized method of visual acuity testing: adaptation of the Early Treatment of Diabetic Retinopathy Study testing protocol
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(02)01825-1
– volume: 111
  start-page: 2076
  year: 2004
  ident: 10.1016/j.ophtha.2009.10.014_bib16
  article-title: A randomized trial of atropine regimens for treatment of moderate amblyopia in children
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2004.04.032
– volume: 12
  start-page: 581
  year: 2008
  ident: 10.1016/j.ophtha.2009.10.014_bib10
  article-title: Further validation of the Amblyopia Treatment Index parental questionnaire
  publication-title: J AAPOS
  doi: 10.1016/j.jaapos.2008.04.017
– volume: 34
  start-page: 187
  year: 1972
  ident: 10.1016/j.ophtha.2009.10.014_bib15
  article-title: Regression models and life-tables
  publication-title: J R Stat Soc Ser B
  doi: 10.1111/j.2517-6161.1972.tb00899.x
– volume: 12
  start-page: 555
  year: 2008
  ident: 10.1016/j.ophtha.2009.10.014_bib17
  article-title: The effect of Bangerter filters on optotype acuity, Vernier acuity, and contrast sensitivity
  publication-title: J AAPOS
  doi: 10.1016/j.jaapos.2008.04.012
– volume: 116;
  start-page: 1475
  year: 2009
  ident: 10.1016/j.ophtha.2009.10.014_bib19
  article-title: Treatment of anisometropic amblyopia with spectacles or in combination with translucent Bangerter filters
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2009.02.023
– volume: 126
  start-page: 1634
  year: 2008
  ident: 10.1016/j.ophtha.2009.10.014_bib2
  article-title: Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial
  publication-title: Arch Ophthalmol
  doi: 10.1001/archophthalmol.2008.107
– volume: 5
  start-page: 250
  year: 2001
  ident: 10.1016/j.ophtha.2009.10.014_bib9
  article-title: The Amblyopia Treatment Index
  publication-title: J AAPOS
  doi: 10.1067/mpa.2001.117097
SSID ssj0006634
Score 2.3428614
Snippet To determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with moderate...
Objective To determine whether visual acuity improvement with Bangerter filters is similar to improvement with patching as initial therapy for children with...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 998
SubjectTerms Amblyopia - physiopathology
Amblyopia - therapy
Biological and medical sciences
Child
Child, Preschool
Eyeglasses
Female
Humans
Male
Medical sciences
Miscellaneous
Occlusive Dressings
Ophthalmology
Sensory Deprivation
Treatment Outcome
Vision disorders
Visual Acuity - physiology
Title A Randomized Trial Comparing Bangerter Filters and Patching for the Treatment of Moderate Amblyopia in Children
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0161642009011853
https://www.clinicalkey.es/playcontent/1-s2.0-S0161642009011853
https://dx.doi.org/10.1016/j.ophtha.2009.10.014
https://www.ncbi.nlm.nih.gov/pubmed/20163869
https://www.proquest.com/docview/733516017
https://pubmed.ncbi.nlm.nih.gov/PMC2864338
Volume 117
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZbCmNQxq5ddil62FtxsGXLkh-zslJWuo2Ssr4ZyZaJS2KHJX1of_2OrEucLiPdXoziWLGd8_lc5POdg9CnTPKMpxkEOTAKElqRQJBUBLLkismSVFGoycnn39LTy-TrFb1y_e4tu2QlR8XdVl7J_0gV9oFcNUv2HyTrfxR2wBjkC1uQMGwfJOPx0YVoynZe34HbOOn6bxybvoIQ_3_uGL26BuJJrV-Jm2LMP0D1-uxJ7XROfKa5TobRndHA-zwaz-Xstl3UomMFWsJ335H9vpiupmI2NyWcunUI23rLJOM3zcgtMtg1BfM6vLem4Mgu_XXHNAogVAk3FKdhXVqE0J4azExnaWtRdVG6rdraLBxcj9rukk3xUJ1qZ2ilm8Wx7xktn0pICGMxo_Qx2oMRIQO0Nz67-HnmzTG4VLbAu7kDx5_skvz-PPPf_JP9hVjCU1OZdifb4pH7abU9P2XyHD2zAQYeG7S8QI9U8xI9ObcpFK9QO8Zr0OAONNiDBnvQYAsaDMdiBxoMoMEAGuxBg9sKO9BgDxpcN9iB5jW6PPkyOT4NbNeNoADndxUIFhNZlbBlrOQFzRRX8OASRRVPdWkgpTgXskqqQsUELEYSC8mKJIsUDGgZv0GDpm3UW4QZ0VNEqUjGwS2XoAAK-Mi4CiWhSTlEsfuv88KWpNedUWa5yz28zo2EdLfUTO8FCQ1R4GctTEmWHcdTJ8bc0Y3BQOaAwh3z2LZ5amk1wDKP8iXJQ50gmUYaWmHH46Zxf6Z1ZI2D-oBzHm7gzN-gg_kQYQe8HAyBfrsnGtXeLHMWxzRKwcAO0YHB4XpyqKOuNIPr2kCoP0DXmN_8pqmnXa15wiFkifm7Xdf1Hj1dK5IPaLD6daM-gru-kof2gfwNv4vvKw
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Randomized+Trial+Comparing+Bangerter+Filters+and+Patching+for+the+Treatment+of+Moderate+Amblyopia+in+Children&rft.jtitle=Ophthalmology+%28Rochester%2C+Minn.%29&rft.date=2010-05-01&rft.pub=Elsevier&rft.issn=0161-6420&rft.volume=117&rft.issue=5&rft.spage=998&rft.epage=1004&rft_id=info:doi/10.1016%2Fj.ophtha.2009.10.014&rft.externalDBID=n%2Fa&rft.externalDocID=22773755
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01616420%2FS0161642009X00187%2Fcov150h.gif